News Focus
News Focus
icon url

CHEVYGUY

07/27/17 12:51 PM

#305778 RE: Protector #305775

So CP in your own words, Ronin increased value from buying 30-50 cents which after the split is 2.10-3.50 In some cases they increased it in 5 months over 100%.

Now lets be fair and say they just increased it 75% from when they came on board, and you find a problem with that?

Im just going by your previous post before your BOD figured out what RONIN was really doing.

Now you want the board to recommend 3 more stooges?

Ronin sure scares the heck out of certain people.
icon url

purpledawgs

07/27/17 1:29 PM

#305787 RE: Protector #305775

Have the two trials even dosed a single patient yet? It is my understanding that a PR would be forthcoming once a patient was actually dosed. Have you seen one?

IMO

PD
icon url

bigbro1

07/27/17 1:57 PM

#305793 RE: Protector #305775

You are misinformed..

Ronin said correctly "Now, well over a year after another clinical failure of bavituximab (the Company's immunotherapy drug candidate), instead of addressing the core problems of the Company, the Board relies on tangential, counterfactual, and straw-man arguments to justify their positions, in desperate attempts to externalize the problems they have created. We believe immediate changes are necessary to stop Peregrine's reckless spending and equity dilution in order to put the Company on the path towards creating value for stockholders and stability for employees."